Uncomplicated Plasmodium Falciparum Malaria Clinical Trial
Official title:
Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers
The purpose of this study is to evaluate the efficiency of a rapid diagnostic test
(Paracheck Pf) for the diagnosis of uncomplicated Plasmodium falciparum malaria by community
health workers at village level in Tanzania and how the use of rapid diagnostic test may
influence prescription of antimalarial drugs.
The hypothesis is that rapid diagnostic tests used by community health workers will reduce
the use of antimalarial drugs (Coartem; Novartis) by 30% without affecting the health
outcome.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06076213 -
Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo
|
Phase 4 | |
| Recruiting |
NCT05842954 -
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria
|
Phase 3 | |
| Completed |
NCT00331136 -
Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Completed |
NCT02083380 -
Phase IIb Study to Investigate the Efficacy of OZ439 & Piperaquine Phosphate Co-administered to Adults & Children With Uncomplicated Plasmodium Falciparum.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05750628 -
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Not yet recruiting |
NCT05951595 -
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
|
Phase 3 | |
| Completed |
NCT03453840 -
Extended Duration Artemether-lumefantrine Treatment for Malaria in Children
|
Phase 4 | |
| Recruiting |
NCT04546633 -
Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Suspended |
NCT01849640 -
Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity
|
N/A | |
| Not yet recruiting |
NCT05764746 -
Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
|
Phase 2/Phase 3 |